Corcept Therapeutics Incorporated (CORT) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Corcept Therapeutics Incorporated · Health Care · ref. ETF XLV · 57 calls · price $117.8
What the company does: Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
📈 Corcept Therapeutics Incorporated (CORT) stock price
$117.8+63.3% over range
Oct 14, 25low $32.15 · high $123.57Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
80% recommend buying · 5 analysts
📊 JPI status :
Corcept Therapeutics Incorporated is part of our 2026 selection (JPI Fair + JPI Risk +), bought at the start of the year and tracked live. It no longer shows in today's ranking: its target has been reached, there is no gap left. See the 2026 selection and its performance →
🎯 CORT price target & analyst consensus — price $118
The price target · all analysts combined (5 targets)
Highest target · 2 firms of 5$165+40.1%
Median target · of 5 targets$161+36.7%
Lowest target · 1 firm of 5$50-57.6%
Current price$117.8
Where these 5 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
360%
$161 ↔ $165
Below
240%
$50 ↔ $72
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: HC Wainwright & Co. — 60% of its targets hit on this sector (329 calls tested). It aims for $165 (+40 %), call made on September 19, 2026, maturing on September 19, 2027 (25 d ago).
The 1 reliable analyst
$165+40 %
The 4 other firms
$117-1.1 %
How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $165 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 5 ratings (last 6 months)
Strong Buy00%
Buy480%
Hold00%
Sell120%
Strong Sell00%
Go deeper on the analysts
🎯 CORT price target all
All 57 calls, one by one, with our verdict on each firm.
→ See all 57 targets, analyst by analyst💡 The best analysts on CORT most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in CORT? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Corcept Therapeutics Incorporated? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on CORT
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Janney Montgomery Scott | 100% | +89.3% | 2 |
| B of A Securities ↗ | 100% | +40.8% | 2 |
| Truist Securities ↗ | 88% | +104.2% | 8 |
| Canaccord Genuity ↗ | 82% | +31.0% | 11 |
| HC Wainwright & Co. ↗ | 74% | +40.9% | 23 |
| Piper Sandler ↗ | 70% | +29.4% | 10 |
| Ladenburg Thalmann ↗ | 50% | +77.6% | 2 |
| B. Riley Securities ↗ | 50% | -9.8% | 2 |
| Stifel ↗ | 0% | -34.5% | 2 |
| Oppenheimer ↗ | 0% | -46.5% | 2 |
📊 What $1,000 invested in Corcept Therapeutics Incorporated would be worth › open the full page
In short — $1,000 invested in Corcept Therapeutics Incorporated 10 years ago would be worth $18,167 today, i.e. +34%/yr on average. Best year: 2017 (+149%), worst: 2025 (-31%). Price performance, excluding dividends.
If I'd invested $1,000 in Corcept Therapeutics Incorporated
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,795 | +80% |
| 3 years ago | $4,454 | +345% |
| 5 years ago | $3,458 | +246% |
Return by year (Corcept Therapeutics Incorporated)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +160% | $2,600 (+160%) |
| 2025 | -31% | $1,795 (+80%) |
| 2024 | +55% | $2,785 (+179%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Corcept Therapeutics Incorporated
Loading news…
📋 All analyst calls on CORT
Filtered on — · ✕ show all
HC Wainwright & Co. ↗
Sep 18, 26
▲ Buy · 🎯$165
Price at call : $113.76 — upside +45%
Today : $117.8 — upside +40%
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Sep 18, 27
matures : Sep 18, 27
Piper Sandler ↗
Jul 30, 26
▲ Overweight · 🎯$165
Price at call : $114.49 — upside +44%
Today : $117.8 — upside +40%
🎯 on CORT : 67% (6 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
Canaccord Genuity ↗
Jul 30, 26
▲ Buy · 🎯$161
Price at call : $114.49 — upside +41%
Today : $117.8 — upside +37%
🎯 on CORT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
HC Wainwright & Co. ↗
Jul 30, 26
▲ Buy · 🎯$165
Price at call : $118.32 — upside +39%
Today : $117.8 — upside +40%
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
Canaccord Genuity ↗
Jul 29, 26
▲ Buy · 🎯$150
Price at call : $118.32 — upside +27%
Today : $117.8 — upside +27%
🎯 on CORT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Jul 29, 27
matures : Jul 29, 27
Wolfe Research ↗
Jul 27, 26
▼ Underperform · 🎯$50
Price at call : $91.12 — upside -45%
Today : $117.8 — upside -58%
🎯 on CORT : no call matured yet · 📊 overall : 34.9% · -2.8% (109 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
Canaccord Genuity ↗
May 28, 26
▲ Buy · 🎯$135
Price at call : $69.49 — upside +94%
Today : $117.8 — upside +15%
🎯 on CORT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
HC Wainwright & Co. ↗
May 28, 26
▲ Buy · 🎯$95
Price at call : $68.38 — upside +39%
Today : $117.8 — upside -19%
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
See the other 49 calls, newest to oldest
▲ Buy · 🎯$72
Price at call : $57.08 — upside +26%
Today : $117.8 — upside -39%
🎯 on CORT : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : May 13, 27
matures : May 13, 27
HC Wainwright & Co. ↗
May 4, 26
▲ Buy · 🎯$75
Price at call : $51.6 — upside +45%
Today : $117.8 — upside -36%
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : May 4, 27
matures : May 4, 27
Piper Sandler ↗
May 1, 26
▲ Overweight · 🎯$88
Price at call : $51.6 — upside +71%
Today : $117.8 — upside -25%
🎯 on CORT : 67% (6 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : May 1, 27
matures : May 1, 27
Canaccord Genuity ↗
Mar 26, 26
▲ Buy · 🎯$110
Price at call : $37.6 — upside +193%
Today : $117.8 — upside -7%
🎯 on CORT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Mar 26, 27
matures : Mar 26, 27
Wolfe Research ↗
Mar 26, 26
■ Peer Perform neutral · not a buy
🎯 on CORT : no call matured yet · 📊 overall : 34.9% · -2.8% (109 calls)
in progress (365j)
matures : Mar 26, 27
matures : Mar 26, 27
HC Wainwright & Co. ↗
Mar 25, 26
▲ Buy · 🎯$60
Price at call : $38.53 — upside +56%
Today : $117.8 — upside -49%
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Mar 25, 27
matures : Mar 25, 27
HC Wainwright & Co. ↗
Feb 25, 26
▲ Buy · 🎯$60
Price at call : $36.22 — upside +66%
Today : $117.8 — upside -49%
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
HC Wainwright & Co. ↗
Feb 20, 26
▲ Buy · 🎯$67
Price at call : $34.82 — upside +92%
Today : $117.8 — upside -43%
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Feb 20, 27
matures : Feb 20, 27
Canaccord Genuity ↗
Jan 23, 26
▲ Buy · 🎯$100
Price at call : $43.98 — upside +127%
Today : $117.8 — upside -15%
🎯 on CORT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Jan 23, 27
matures : Jan 23, 27
HC Wainwright & Co. ↗
Jan 23, 26
▲ Buy · 🎯$105
Price at call : $43.98 — upside +139%
Today : $117.8 — upside -11%
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Jan 23, 27
matures : Jan 23, 27
Canaccord Genuity ↗
Jan 2, 26
▲ Buy · 🎯$99
Price at call : $38.2 — upside +159%
Today : $117.8 — upside -16%
🎯 on CORT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Jan 2, 27
matures : Jan 2, 27
HC Wainwright & Co. ↗
Jan 2, 26
▲ Buy · 🎯$90
Price at call : $38.2 — upside +136%
Today : $117.8 — upside -24%
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Jan 2, 27
matures : Jan 2, 27
■ Neutral neutral · not a buy · 🎯$95
Price at call : $81.12 — gap to target +17%
Today : $117.8 — gap to target -19%
🎯 on CORT : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Dec 16, 26
matures : Dec 16, 26
HC Wainwright & Co. ↗
Nov 25, 25
▲ Buy · 🎯$145
Price at call : $80.28 — upside +81%
Today : $117.8 — upside +23%
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Nov 25, 26
matures : Nov 25, 26
Wolfe Research ↗
Nov 18, 25
■ Peer Perform neutral · not a buy
🎯 on CORT : no call matured yet · 📊 overall : 34.9% · -2.8% (109 calls)
in progress (365j)
matures : Nov 18, 26
matures : Nov 18, 26
HC Wainwright & Co. ↗
Oct 20, 25
▲ Buy · 🎯$145
Price at call : $75.39 — upside +92%
Today : $117.8 — upside +23%
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Oct 20, 26
matures : Oct 20, 26
HC Wainwright & Co. ↗
Oct 10, 25
▲ Buy · 🎯$145
Price at call : $73.96 — upside +96%
Today : $117.8 — upside +23%
Expected +96% · Actual +64% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+63.9%
stock +64% · XLV +21%
matured Oct 10, 26
Canaccord Genuity ↗
Sep 25, 25
▲ Buy · 🎯$140
Price at call : $82.73 — upside +69%
Today : $117.8 — upside +19%
Expected +69% · Actual +40% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+40.3%
stock +40% · XLV +27%
matured Sep 25, 26
Canaccord Genuity ↗
Sep 10, 25
▲ Buy · 🎯$140
Price at call : $74.33 — upside +88%
Today : $117.8 — upside +19%
Expected +88% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+51.7%
stock +52% · XLV +18%
matured Sep 10, 26
Canaccord Genuity ↗
Aug 1, 25
▲ Buy · 🎯$137
Price at call : $71.77 — upside +91%
Today : $117.8 — upside +16%
Expected +91% · Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+57.2%
stock +57% · XLV +22%
matured Aug 1, 26
Piper Sandler ↗
Aug 1, 25
▲ Overweight · 🎯$121
Price at call : $69 — upside +75%
Today : $117.8 — upside +3%
Expected +75% · Actual +63% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 67% (6 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
+63.5%
stock +63% · XLV +24%
matured Aug 1, 26
HC Wainwright & Co. ↗
May 6, 25
▲ Buy · 🎯$145
Price at call : $70.74 — upside +105%
Today : $117.8 — upside +23%
Expected +105% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-26.3%
stock -26% · XLV +8%
matured May 6, 26
Piper Sandler ↗
Apr 3, 25
■ Neutral neutral · not a buy · 🎯$150
Price at call : $79.37 — gap to target +89%
Today : $117.8 — gap to target +27%
🎯 on CORT : 67% (6 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : Apr 3, 26
matures : Apr 3, 26
Piper Sandler ↗
Apr 3, 25
▲ Overweight · 🎯$131
Price at call : $79.37 — upside +65%
Today : $117.8 — upside +11%
Expected +65% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on CORT : 67% (6 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-48.5%
stock -49% · XLV +2%
matured Apr 3, 26
Canaccord Genuity ↗
Apr 1, 25
▲ Buy · 🎯$142
Price at call : $83.81 — upside +69%
Today : $117.8 — upside +21%
Expected +69% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on CORT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
-49.3%
stock -49% · XLV +2%
matured Apr 1, 26
Truist Securities ↗
Mar 31, 25
▲ Buy · 🎯$150
Price at call : $91.93 — upside +63%
Today : $117.8 — upside +27%
Expected +63% · Actual -54% · Reason (≥ +15%) : ✗ No
🎯 on CORT : 67% (3 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-54.3%
stock -54% · XLV +3%
matured Mar 31, 26
HC Wainwright & Co. ↗
Mar 31, 25
▲ Buy · 🎯$150
Price at call : $91.93 — upside +63%
Today : $117.8 — upside +27%
Expected +63% · Actual -54% · Reason (≥ +15%) : ✗ No
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-54.3%
stock -54% · XLV +3%
matured Mar 31, 26
Piper Sandler ↗
Feb 27, 25
▲ Overweight · 🎯$78
Price at call : $59.85 — upside +30%
Today : $117.8 — upside -34%
Expected +30% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on CORT : 67% (6 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
-40.4%
stock -40% · XLV +9%
matured Feb 27, 26
HC Wainwright & Co. ↗
Feb 27, 25
▲ Buy · 🎯$115
Price at call : $59.85 — upside +92%
Today : $117.8 — upside -2%
Expected +92% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-40.4%
stock -40% · XLV +9%
matured Feb 27, 26
HC Wainwright & Co. ↗
Feb 11, 25
▲ Buy · 🎯$115
Price at call : $68.11 — upside +69%
Today : $117.8 — upside -2%
Expected +69% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-40.1%
stock -40% · XLV +7%
matured Feb 11, 26
HC Wainwright & Co. ↗
Feb 7, 25
▲ Buy · 🎯$80
Price at call : $68.01 — upside +18%
Today : $117.8 — upside -32%
Expected +18% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
-39.3%
stock -39% · XLV +7%
matured Feb 7, 26
Canaccord Genuity ↗
Jan 30, 25
▲ Buy · 🎯$130
Price at call : $66.92 — upside +94%
Today : $117.8 — upside +10%
Expected +94% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on CORT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
-39.2%
stock -39% · XLV +6%
matured Jan 30, 26
HC Wainwright & Co. ↗
Oct 31, 24
▲ Buy · 🎯$80
Price at call : $48.97 — upside +63%
Today : $117.8 — upside -32%
Expected +63% · Actual +50% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+50.0%
stock +50% · XLV -2%
matured Oct 31, 25
HC Wainwright & Co. ↗
Oct 18, 24
▲ Buy · 🎯$80
Price at call : $49.75 — upside +61%
Today : $117.8 — upside -32%
Expected +61% · Actual +58% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+58.0%
stock +58% · XLV -5%
matured Oct 18, 25
Truist Securities ↗
Sep 30, 24
▲ Buy · 🎯$76
Price at call : $46.75 — upside +63%
Today : $117.8 — upside -35%
Expected +63% · Actual +80% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 67% (3 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
+80.2%
stock +80% · XLV -6%
matured Sep 30, 25
Piper Sandler ↗
Sep 18, 24
▲ Overweight · 🎯$67
Price at call : $40.92 — upside +64%
Today : $117.8 — upside -43%
Expected +64% · Actual +97% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 67% (6 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
+96.8%
stock +97% · XLV -12%
matured Sep 18, 25
Canaccord Genuity ↗
Jul 31, 24
▲ Buy · 🎯$78
Price at call : $38.67 — upside +102%
Today : $117.8 — upside -34%
Expected +102% · Actual +74% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+73.7%
stock +74% · XLV -13%
matured Jul 31, 25
Canaccord Genuity ↗
Jul 30, 24
▲ Buy · 🎯$38
Price at call : $38.67 — upside -2%
Today : $117.8 — upside -68%
Expected -2% · Actual +74% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+73.7%
stock +74% · XLV -13%
matured Jul 30, 25
Piper Sandler ↗
Jul 30, 24
▲ Overweight · 🎯$38
Price at call : $36.12 — upside +5%
Today : $117.8 — upside -68%
Expected +5% · Actual +94% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 67% (6 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
+93.5%
stock +94% · XLV -11%
matured Jul 30, 25
HC Wainwright & Co. ↗
Jul 30, 24
▲ Buy · 🎯$45
Price at call : $36.12 — upside +25%
Today : $117.8 — upside -62%
Expected +25% · Actual +94% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+93.5%
stock +94% · XLV -11%
matured Jul 30, 25
Piper Sandler ↗
Jul 1, 24
▲ Overweight · 🎯$35
Price at call : $31.56 — upside +11%
Today : $117.8 — upside -70%
Expected +11% · Actual +126% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 67% (6 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
+126.0%
stock +126% · XLV -6%
matured Jul 1, 25
Truist Securities ↗
Jun 17, 24
▲ Buy · 🎯$65
Price at call : $28.15 — upside +131%
Today : $117.8 — upside -45%
Expected +131% · Actual +153% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 67% (3 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
+153.1%
stock +153% · XLV -9%
matured Jun 17, 25
HC Wainwright & Co. ↗
May 29, 24
▲ Buy · 🎯$40
Price at call : $31.53 — upside +27%
Today : $117.8 — upside -66%
Expected +27% · Actual +146% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+146.2%
stock +146% · XLV -7%
matured May 29, 25
HC Wainwright & Co. ↗
May 2, 24
▲ Buy · 🎯$40
Price at call : $24.52 — upside +63%
Today : $117.8 — upside -66%
Expected +63% · Actual +202% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+201.5%
stock +202% · XLV -2%
matured May 2, 25
HC Wainwright & Co. ↗
Apr 23, 24
▲ Buy · 🎯$38
Price at call : $22.48 — upside +69%
Today : $117.8 — upside -68%
Expected +69% · Actual +219% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 58% (12 calls matureds) · 📊 on Health : 57.4% · +25.1% (329 calls)
+219.3%
stock +219% · XLV -2%
matured Apr 23, 25
Canaccord Genuity ↗
Dec 13, 23
▲ Buy · 🎯$38
Price at call : $29.83 — upside +27%
Today : $117.8 — upside -68%
Expected +27% · Actual +86% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+85.7%
stock +86% · XLV +4%
matured Dec 12, 24
Canaccord Genuity ↗
Aug 25, 23
▲ Buy · 🎯$35
Price at call : $32.22 — upside +9%
Today : $117.8 — upside -70%
Expected +9% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on CORT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+8.6%
stock +9% · XLV +16%
matured Aug 24, 24
Canaccord Genuity ↗
Mar 8, 23
▲ Buy · 🎯$32
Price at call : $21.01 — upside +52%
Today : $117.8 — upside -73%
Expected +52% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on CORT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+11.3%
stock +11% · XLV +16%
matured Mar 7, 24
Canaccord Genuity ↗
Feb 2, 22
▲ Buy · 🎯$30
Price at call : $19.26 — upside +56%
Today : $117.8 — upside -75%
Expected +56% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on CORT : 82% (11 calls matureds) · 📊 on Health : 39.9% · -0.9% (148 calls)
+27.1%
stock +27% · XLV -0%
matured Feb 2, 23
Frequently asked questions
Should I buy Corcept Therapeutics Incorporated stock?
This isn't buy advice. For Corcept Therapeutics Incorporated, the analyst consensus is "Buy", with an average price target of $161 (+37% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Corcept Therapeutics Incorporated). We show the numbers — you decide.
Is it too late to buy Corcept Therapeutics Incorporated? How high can it go?
The most bullish analyst target on Corcept Therapeutics Incorporated is $165 (+40% above today's price); the average is $161. That's the upside they see. Check how reliable those analysts have actually been on Corcept Therapeutics Incorporated on our site before trusting it.
Is Corcept Therapeutics Incorporated still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 10 analysts have a real record on Corcept Therapeutics Incorporated, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Corcept Therapeutics Incorporated? The case for and against
The arguments for and against, one by one, from the numbers: why invest in CORT (and why hesitate).
What has Corcept Therapeutics Incorporated's past performance been?
Historical returns and a "how much if I had invested" calculator: CORT performance & returns.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX